Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Sheridan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Viral Hepatitis|May 6, 2017
Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug usersI T Shawa, D J Felmlee, D Hegazy, et al.
Seminars in Immunopathology|November 1, 2012
Lipids and HCVM F Bassendine, D A Sheridan, S H Bridge, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2009
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirinD A Sheridan, D A Price, M L Schmid, et al.
Clinics and Research in Hepatology and Gastroenterology|November 15, 2016
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?M F Bassendine, S U Nielsen, S H Bridge, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Viral Hepatitis|May 6, 2017
Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug usersI T Shawa, D J Felmlee, D Hegazy, et al.
Seminars in Immunopathology|November 1, 2012
Lipids and HCVM F Bassendine, D A Sheridan, S H Bridge, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2009
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirinD A Sheridan, D A Price, M L Schmid, et al.
Clinics and Research in Hepatology and Gastroenterology|November 15, 2016
Hepatitis C virus and atherosclerosis: A legacy after virologic cure?M F Bassendine, S U Nielsen, S H Bridge, et al.
Pageof 1